Atlantic Edge Private Wealth Management’s AbbVie ABBV Stock Holding History

Atlantic Edge Private Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$608K	Buy	2,417 +1	+0%	+$215	0.12%	96
2026 Q1	$526K	Sell	2,416 -25	-1%	-$5.55K	0.13%	93
2025 Q4	$558K	Sell	2,441 -34	-1%	-$7.75K	0.14%	90
2025 Q3	$573K	Sell	2,475 -42	-2%	-$8.55K	0.15%	89
2025 Q2	$467K	Sell	2,517 -159	-6%	-$29.6K	0.13%	93
2025 Q1	$561K	Sell	2,676 -75	-3%	-$14.6K	0.17%	89
2024 Q4	$489K	Sell	2,751 -124	-4%	-$22.8K	0.15%	90
2024 Q3	$568K	Buy	2,875 +11	+0.4%	+$2.05K	0.17%	91
2024 Q2	$491K	Buy	2,864 +15	+0.5%	+$2.48K	0.16%	92
2024 Q1	$519K	Buy	2,849 +1,353	+90%	+$233K	0.18%	91
2023 Q4	$232K	Buy	+1,496	New	+$218K	0.09%	115

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Atlantic Edge Private Wealth Management's ABBV Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management increased its AbbVie (ABBV) stake by 0.04% in Q2 2026, buying an estimated $215 and bringing the position to 2,417 shares worth $608K. The position accounts for 0.12% of the portfolio, ranked #96.

Atlantic Edge Private Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,775 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Atlantic Edge Private Wealth Management held 2,417 shares of AbbVie worth $608K as of Q2 2026.
Atlantic Edge Private Wealth Management bought 1 AbbVie share in Q2 2026, an estimated $215.
AbbVie made up 0.12% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #96 holding.
Atlantic Edge Private Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
1,775 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.